| D0012-0013 | Doxorubicin Dimer Impurity 1 | 2755741-04-7 | Impurity |
| D0012-0015 | Doxorubicin Process Impurity 1 | 68168-15-0 | Impurity |
| D0012-0040 | Doxorubicin Impurity 14 | 73952-94-0 | Impurity |
| D0012-0041 | Doxorubicin Hydrochloride Impurity 15 | 32434-04-1 | Impurity |
| D0012-0044 | Doxorubicin Hydrochloride Impurity 17 | 32384-98-8 | Impurity |
| D0012-0047 | Doxorubicin Impurity 18 | 59325-97-2 | Impurity |
| D0012-0049 | Doxorubicin Impurity 19Q: What is Doxorubicin Impurity 19 Q: What is the CAS Number of Doxorubicin Impurity 19 | 201278-93-5 | Impurity |
| D0012-0050 | Doxorubicin Hydrochloride Impurity 20 | 80948-70-5 | Impurity |
| D0012-0056 | Doxorubicin Hydrochloride Impurity 23 | 2183522-38-3 | Impurity |
| D0012-0061 | Doxorubicin Hydrochloride Impurity 26 | 121250-06-4 | Impurity |
| D0012-0063 | Doxorubicin Impurity 26 | 189289-22-3 | Impurity |
| D0012-0067 | Doxorubicin Hydrochloride Impurity 29 | 210837-88-0 | Impurity |
| D0012-0069 | Doxorubicin Hydrochloride Impurity 30 | 26295-56-7 | Impurity |
| D0012-0120 | Doxorubicin Hydrochloride Impurity 74 | 286010-07-9 | Impurity |
| D0012-0126 | Doxorubicin Hydrochloride Impurity 79 | 1159977-23-7 | Impurity |
| D0012-0132 | Daun02 | 290304-24-4 | Related substance |
| D0012-0181 | (1R,2S,3S,4S,4aS,9aS,10S)-1,3,4-Trihydroxy-5,10-dimethoxy-2-methyl-3-((2R,3S)-3-methyloxirane-2-carbonyl)-1,2,3,4-tetrahydro-4a,9a-epoxyanthracen-9(10H)-one | 808750-39-2 | Related substance |
| D0012-0182 | (2R,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,12-dihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboxylic acid | 69429-21-6 | Related substance |
| D0012-0183 | (2R,4S,5S,6S)-4-amino-6-methyltetrahydro-2H-pyran-2,5-diol | 26548-47-0 | Related substance |
| D0012-0189 | (7R,9S)-9-acetyl-6,7,9,11-tetrahydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | 59325-98-3 | Related substance |
| D0012-0190 | (7R,9S)-9-acetyl-6,9,11-trihydroxy-4,7-dimethoxy-8,10-dihydro-7H-tetracene-5,12-dione | 90410-90-5 | Related substance |
| D0012-0191 | (7S,9S)-7-[(2R,4R,5S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4,6,9,11-tetrahydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione | 69401-50-9 | Related substance |
| D0012-0192 | (8R,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione | 628290-43-7 | Related substance |
| D0012-0195 | (8S,10R)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione | 98632-73-6 | Related substance |
| D0012-0196 | (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,6,8,11-tetrahydroxy-8-(1-hydroxyethyl)-7,8,9,10-tetrahydrotetracene-5,12-dione | 62182-86-9 | Related substance |
| D0012-0202 | (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride | 25316-40-9 | Salt / salt form |
| D0012-0210 | (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-chloro-1,1-dimethoxyethyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione | 742671-66-5 | Related substance |
| D0012-0214 | (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-ethyl-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione | 79466-09-4 | Related substance |
| D0012-0215 | (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-ethyl-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride | 65360-28-3 | Salt / salt form |
| D0012-0222 | (8S,10S)-8-(2-bromoacetyl)-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione | 29742-69-6 | Related substance |
| D0012-0223 | (8S,10S)-8-(2-chloroacetyl)-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione | 121720-15-8 | Related substance |
| D0012-0227 | (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-α-L-arabino-hexopyranosyl)oxy]-8-(bromoacetyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride | 99530-17-3 | Salt / salt form |
| D0012-0228 | (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione | 131086-18-5 | Related substance |
| D0012-0229 | (8S-cis)-8-Acetyl-10-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione | 111248-01-2 | Related substance |
| D0012-0232 | (S)-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-9-(2-hydroxyacetyl)-4-methoxy-7,8-dihydrotetracene-5,12-dione | 80996-23-2 | Related substance |
| D0012-0242 | (S)-9-acetyl-6,7,11-trihydroxy-4-methoxy-7,8-dihydrotetracene-5,12-dione | 80948-67-0 | Related substance |
| D0012-0243 | (S)-9-acetyl-7-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,11-dihydroxy-4-methoxy-7,8-dihydrotetracene-5,12-dione hydrochloride | 68168-14-9 | Salt / salt form |
| D0012-0246 | 1-Demethyl Hydroxy Daunomycinone | 58199-98-7 | Related substance |
| D0012-0249 | 11-Deoxydoxorubicin | 71800-89-0 | Related substance |
| D0012-0250 | 1H-Pyrrole-1-hexanoic acid, 2,5-dihydro-2,5-dioxo-, 2-[1-[(2S,4S)-4-[(3-amino-2,3,6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl]-2-hydroxyethylidene]hydrazide, hydrochloride (1:1) | 480998-12-7 | Salt / salt form |
| D0012-0251 | 2-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-2-oxoacetaldehyde | 117903-06-7 | Related substance |
| D0012-0255 | 3,4-Diepi-Doxorubicin Hydrochloride | 73069-23-5 | Salt / salt form |
| D0012-0258 | 4-((S)-2-((S)-2-amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((2S,3S,4S,6R)-3-hydroxy-2-methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)carbamate | 1022094-34-3 | Related substance |
| D0012-0261 | 5,12-Naphthacenedione, 6,11-dihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy | 677726-67-9 | Related substance |
| D0012-0263 | 6,11-DIHYDROXY-5,12-NAPHTHACENEDIONE | 1785-52-0 | Related substance |
| D0012-0265 | 6,11-dihydroxy-8-(2-hydroxyacetyl)-1-methoxytetracene-5,12-dione | 105612-58-6 | Related substance |
| D0012-0269 | 6,8,11-trihydroxy-1-methoxytetracene-5,12-dione | 64845-67-6 | Related substance |
| D0012-0270 | 7-Deoxy Doxorubicin Aglycone (> 75%) | 38554-25-5 | Related substance |
| D0012-0275 | 8-Acetyl-6,10,11-trihydroxy-1-methoxy-5,12-naphthacenedione | 20982-41-6 | Related substance |
| D0012-0281 | [4-Amino-3-(hydroxymethyl)phenyl]methanol | 1009314-88-8 | Related substance |
| D0012-0283 | DAUNOSAMINE | 4305-54-8 | Related substance |
| D0012-0285 | Doxorubicin 13CD3 TFA saltQ: What is Doxorubicin 13CD3 TFA salt Q: What is the CAS Number of Doxorubicin 13CD3 TFA salt Q: What is the storage condition of Doxorubicin 13CD3 TFA salt Q: What are the applications of Doxorubicin 13CD3 TFA salt | 1224610-76-7 | Related substance |
| D0012-0297 | Doxorubicin Impurity 9 | 18977-93-0 | Impurity |
| D0012-0299 | Doxorubicin-hydrazone-caproyl-maleimide | 151038-96-9 | Related substance |
| D0012-0300 | doxorubicin-N-4-hydroxyphenoxyacetamide | 131089-08-2 | Related substance |
| D0012-0301 | Doxorubicin-SMCC | 400647-59-8 | Related substance |
| D0012-0308 | N'-((E)-1-((2S,4S)-4-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)-2-hydroxyethylidene)-6-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanehydrazide | 1361644-26-9 | Related substance |
| D0012-0309 | N-((2S,3S,4S,6R)-3-hydroxy-2-Methyl-6-(((1S,3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl)oxy)tetrahydro-2H-pyran-4-yl)-1-(5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)-3,6,9,12-tetraoxapentadecan-15-amide | 3026061-31-1 | Related substance |
| D0012-0311 | N-(Iodoacetamido)-Doxorubicin | 114390-30-6 | Related substance |
| D0012-0315 | Doxorubicin Impurity 2 | 148218-14-8 | Impurity |
| D0012-0316 | Doxorubicin Impurity 2 | 106401-68-7 | Impurity |
| D0012-0317 | Doxorubicin Impurity 3 | 65026-79-1 | Impurity |
| D0012-0318 | Doxorubicin Impurity 3 | 60873-68-9 | Impurity |